Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Metronomic Treatment of Vinorelbine With Oral Capecitabine Is Tolerable in the Randomized Phase 2 Study XeNa Including Patients With HER2 Non-Amplified Metastatic Breast CancerActa Oncol 2020 Dec 01;[EPub Ahead of Print], AS Brems-Eskildsen, S Linnet, H Danø, A Luczak, PM Vestlev, EH Jakobsen, J Neimann, CB Jensen, T Dongsgaard, ST Langkjer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.